Studies, such as those published in Cell Metabolism, suggest that GLP-1 can dampen this reward response, making these foods seem less appealing and reducing cravings
As shown in this study, despite receiving PTA and PTE under the Hatch Waxman Act to compensate for the loss of any patent term of the main compound once a drug is approved, in this hyper financialized economy it is not enough
Boehringer Ingelheim
S., Pduraru, L., Yahya, G., Metwally, K., & Cavalu, S
In our view, the strategic priority is shifting away from higher potency and toward maximizing patient adherencethe true driver of long-term health outcomes and recurring revenue
Promotes a more balanced relationship with food